These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6116646)

  • 21. CSF Vasopressin and cyclic nucleotide concentrations in senile dementia.
    Tsuji M; Takahashi S; Akazawa S
    Psychoneuroendocrinology; 1981; 6(2):171-6. PubMed ID: 6275436
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuroendocrinology of cerebrospinal fluid: peptides, steroids, and other hormones.
    Wood JH
    Neurosurgery; 1982 Aug; 11(2):293-305. PubMed ID: 6126839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function.
    Post RM; Gold P; Rubinow DR; Ballenger JC; Bunney WE; Goodwin FK
    Life Sci; 1982 Jul; 31(1):1-15. PubMed ID: 6180277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of hypothalamic hormones in the mid-term human fetal cerebrospinal fluid.
    Masudi NA; Gilmore DP; Wilson CA; McNeilly AS
    J Pak Med Assoc; 1985 Nov; 35(11):337-40. PubMed ID: 3935820
    [No Abstract]   [Full Text] [Related]  

  • 25. Cerebrospinal fluid somatostatin in delirium.
    Koponen H; Stenbäck U; Mattila E; Reinikainen K; Soininen H; Riekkinen PJ
    Psychol Med; 1989 Aug; 19(3):605-9. PubMed ID: 2572025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical relevance of ferritin concentration in the cerebrospinal fluid.
    Sindic CJ; Collet-Cassart D; Cambiaso CL; Masson PL; Laterre EC
    J Neurol Neurosurg Psychiatry; 1981 Apr; 44(4):329-33. PubMed ID: 7241160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of neuropeptides in neurological diseases.
    Sagar SM; Beal MF; Marshall PE; Landis DM; Martin JB
    Peptides; 1984; 5 Suppl 1():255-62. PubMed ID: 6207511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GH response to GH-releasing hormone (GHRH) in Alzheimer and vascular dementia. Relation with somatostatin cerebrospinal levels.
    Gómez IM; Aguilar M; Navarro MA; Ortolà J; Soler J
    Ann Endocrinol (Paris); 1996; 57(2):107-10. PubMed ID: 8881289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
    Strittmatter M; Cramer H; Reuner C; Strubel D; Hamann G; Schimrigk K
    Biol Psychiatry; 1997 Jun; 41(11):1124-30. PubMed ID: 9146823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated CSF somatostatin concentrations in demented patients parallel improved psychomotor functions induced by integrity-promoting care.
    Widerlöv E; Bråne G; Ekman R; Kihlgren M; Norberg A; Karlsson I
    Acta Psychiatr Scand; 1989 Jan; 79(1):41-7. PubMed ID: 2564721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonopioid neuropeptides in mammalian CNS.
    Iversen LL
    Annu Rev Pharmacol Toxicol; 1983; 23():1-27. PubMed ID: 6191652
    [No Abstract]   [Full Text] [Related]  

  • 32. Somatostatin-like immunoreactivity in the cerebrospinal fluid of neurological patients.
    Kohler J; Schröter E; Cramer H
    Arch Psychiatr Nervenkr (1970); 1982; 231(6):503-8. PubMed ID: 6127989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoreactive substance P and somatostatin in the cerebrospinal fluid of senile parkinsonian patients.
    Cramer H; Rissler K; Rösler N; Strubel D; Schaudt D; Kuntzmann F
    Eur Neurol; 1989; 29(1):1-5. PubMed ID: 2468498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid: detection of tumors and disk herniations with MR spectroscopy.
    Koschorek F; Gremmel H; Stelten J; Offermann W; Leibfritz D
    Radiology; 1988 Jun; 167(3):813-6. PubMed ID: 3363147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diazepam binding inhibitor in brain and in cerebrospinal fluid of human.
    Ferrero P; Penna P; Vischia F; Tarenzi L; Bergamasco B; Bergamini L
    Ann Ist Super Sanita; 1988; 24(3):443-59. PubMed ID: 3190067
    [No Abstract]   [Full Text] [Related]  

  • 37. Cerebrospinal fluid and plasma concentrations of SRIH, beta-endorphin, CRH, NPY and GHRH in obese and normal weight subjects.
    Brunani A; Invitti C; Dubini A; Piccoletti R; Bendinelli P; Maroni P; Pezzoli G; Ramella G; Calogero A; Cavagnini F
    Int J Obes Relat Metab Disord; 1995 Jan; 19(1):17-21. PubMed ID: 7719386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid and serum levels of albumin, IgG, IgA and IgM in patients with intracranial tumors and lumbar disc herniation.
    Rao ML; Böker DK
    Eur Neurol; 1987; 26(4):241-5. PubMed ID: 3595664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbamazepine increases cerebrospinal fluid thyrotropin-releasing hormone levels in affectively ill patients.
    Marangell LB; George MS; Bissette G; Pazzaglia P; Huggins T; Post RM
    Arch Gen Psychiatry; 1994 Aug; 51(8):625-8. PubMed ID: 8042911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Somatostatin and vasoactive intestinal polypeptide in the cerebrospinal fluid of patients with neurological disorders].
    Shimatsu A; Kato Y; Tatsuoka Y; Yoshida K; Imura H
    Rinsho Shinkeigaku; 1985 Nov; 25(11):1305-10. PubMed ID: 2871957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.